Biotech Losers In News: Agios Pharmaceuticals (NASDAQ:AGIO), Cell Therapeutics (NASDAQ:CTIC), NewLink Genetics (NASDAQ:NLNK), Mirati Therapeutics (NASDAQ:MRTX)

Agios Pharmaceuticals, Inc. (NASDAQ:AGIO) present at the Cowen and Company 34th Annual Health Care Conference at the Boston Marriott Copley Place. Agios Pharmaceuticals Inc (NASDAQ:AGIO) stock performance was -5.69% in last session and finished the day at $29.48. Traded volume was 263,884 million shares in the last session and the average volume of the stock remained 254.15 million shares. Agios Pharmaceuticals Inc (NASDAQ:AGIO) insider ownership … Continue reading Biotech Losers In News: Agios Pharmaceuticals (NASDAQ:AGIO), Cell Therapeutics (NASDAQ:CTIC), NewLink Genetics (NASDAQ:NLNK), Mirati Therapeutics (NASDAQ:MRTX)

Trending Tickers: Southern Company (NYSE:SO), Ariad Pharmaceuticals Inc. (NASDAQ:ARIA), Pacific Mercantile Bancorp (NASDAQ:PMBC), MicroFinancial Inc. (NASDAQ:MFI), Mirati Therapeutics, Inc. (NASDAQ:MRTX)

The Southern Company (NYSE:SO) CEO Stan W. Connally sold 16,164 shares of the company’s stock on the open market in a transaction that occurred on Thursday, October 30th. The stock was sold at an average price of $46.17, for a total transaction of $746,291.88. Southern Company (NYSE:SO) belongs to Utilities sector. Its net profit margin is 12.30% and weekly performance is 1.21%. On last trading … Continue reading Trending Tickers: Southern Company (NYSE:SO), Ariad Pharmaceuticals Inc. (NASDAQ:ARIA), Pacific Mercantile Bancorp (NASDAQ:PMBC), MicroFinancial Inc. (NASDAQ:MFI), Mirati Therapeutics, Inc. (NASDAQ:MRTX)

Big Movers : BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX), Mirati Therapeutics, Inc. (NASDAQ:MRTX), Eastman Chemical Co. (NYSE:EMN), Pike Corporation (NYSE:PIKE), General Motors Company (NYSE:GM)

BioCryst Pharmaceuticals (NASDAQ:BCRX) CFO Thomas R. Staab II unloaded 10,000 shares of BioCryst Pharmaceuticals stock in a transaction that occurred on Wednesday, August 27th. The shares were sold at an average price of $13.58, for a total transaction of $135,800.00. Following the completion of the transaction, the chief financial officer now directly owns 162,942 shares in the company, valued at approximately $2,212,752. BioCryst Pharmaceuticals, Inc. … Continue reading Big Movers : BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX), Mirati Therapeutics, Inc. (NASDAQ:MRTX), Eastman Chemical Co. (NYSE:EMN), Pike Corporation (NYSE:PIKE), General Motors Company (NYSE:GM)

Eye Catching Stocks : Micron Technology (NASDAQ:MU), Mirati Therapeutics (NASDAQ:MRTX), Revlon (NYSE:REV), Strayer Education Inc. (NASDAQ:STRA), Shanda Games Limited (NASDAQ:GAME)

On Aug 26, Zacks Investment Research upgraded Micron Technology Inc. (NASDAQ:MU) to a Zacks Rank #1 (Strong Buy) on the back of positive estimate revisions and favorable memory market conditions. Micron Technology Inc. (NASDAQ:MU) belongs to Technology sector. Its net profit margin is 24.10% and weekly performance is -5.12%. On last trading day company shares ended up $31.51. Micron Technology Inc. (NASDAQ:MU) distance from 50-day … Continue reading Eye Catching Stocks : Micron Technology (NASDAQ:MU), Mirati Therapeutics (NASDAQ:MRTX), Revlon (NYSE:REV), Strayer Education Inc. (NASDAQ:STRA), Shanda Games Limited (NASDAQ:GAME)